Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Technologies is a medical device and biotechnology company specializing in the development and production of innovative products for cardiovascular surgery and regenerative medicine. The company is best known for its advanced surgical materials, including biological glues and hemostatic agents designed to improve patient outcomes in complex surgical procedures. New Technologies operates manufacturing facilities that adhere to international quality standards, providing essential tools for surgeons in the Russian and international markets. Their product portfolio focuses on enhancing the safety and efficiency of surgical interventions through the application of cutting-edge biomaterials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Technologies.